Shopping Cart
- Remove All
- Your shopping cart is currently empty
TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells. |
Alias | FSL 1 |
Molecular Weight | 1666.16 |
Formula | C84H140N14O18S |
Cas No. | 322455-70-9 |
Relative Density. | no data available |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O: 2 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.